Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- BAF845 - Provider product page
- Provider
- R&D Systems
- Product name
- Mouse CCL1/I-309/TCA-3 Biotinylated Antibody
- Antibody type
- Polyclonal
- Description
- Antigen Affinity-purified. Detects mouse CCL1/I-309/TCA-3 in ELISAs and Western blots. In sandwich immunoassays, less than 0.05% cross-reactivity with recombinant human I-309, recombinant mouse (rm) Eotaxin-2, rmTARC, and rmMIP-3 beta is observed.
- Reactivity
- Mouse
- Host
- Goat
- Conjugate
- Biotin
- Antigen sequence
P10146
- Isotype
- IgG
- Vial size
- 50 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Response patterns of cytokines/chemokines in two murine strains after irradiation.
Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway.
CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling.
Synthesis of several chemokines but few cytokines by primed uncommitted precursor CD4 T cells suggests that these cells recruit other immune cells without exerting direct effector functions.
Zhang M, Yin L, Zhang K, Sun W, Yang S, Zhang B, Salzman P, Wang W, Liu C, Vidyasagar S, Zhang L, Ju S, Okunieff P, Zhang L
Cytokine 2012 May;58(2):169-77
Cytokine 2012 May;58(2):169-77
Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway.
Kearley J, Buckland KF, Mathie SA, Lloyd CM
American journal of respiratory and critical care medicine 2009 May 1;179(9):772-81
American journal of respiratory and critical care medicine 2009 May 1;179(9):772-81
CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling.
Kearley J, Robinson DS, Lloyd CM
The Journal of allergy and clinical immunology 2008 Sep;122(3):617-24.e6
The Journal of allergy and clinical immunology 2008 Sep;122(3):617-24.e6
Synthesis of several chemokines but few cytokines by primed uncommitted precursor CD4 T cells suggests that these cells recruit other immune cells without exerting direct effector functions.
Yang L, Mosmann T
European journal of immunology 2004 Jun;34(6):1617-26
European journal of immunology 2004 Jun;34(6):1617-26
No comments: Submit comment
No validations: Submit validation data